CID 153270
Pralnacasan
Structural Information
- Molecular Formula
- C26H29N5O7
- SMILES
- CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN3N2C(=O)[C@H](CCC3=O)NC(=O)C4=NC=CC5=CC=CC=C54
- InChI
- InChI=1S/C26H29N5O7/c1-2-37-26-18(14-21(33)38-26)29-23(34)19-8-5-13-30-20(32)10-9-17(25(36)31(19)30)28-24(35)22-16-7-4-3-6-15(16)11-12-27-22/h3-4,6-7,11-12,17-19,26H,2,5,8-10,13-14H2,1H3,(H,28,35)(H,29,34)/t17-,18-,19-,26+/m0/s1
- InChIKey
- CXAGHAZMQSCAKJ-WAHHBDPQSA-N
- Compound name
- (4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 524.21398 | 223.1 |
[M+Na]+ | 546.19592 | 224.6 |
[M-H]- | 522.19942 | 231.2 |
[M+NH4]+ | 541.24052 | 225.3 |
[M+K]+ | 562.16986 | 226.7 |
[M+H-H2O]+ | 506.20396 | 211.4 |
[M+HCOO]- | 568.20490 | 231.7 |
[M+CH3COO]- | 582.22055 | 249.8 |
[M+Na-2H]- | 544.18137 | 219.4 |
[M]+ | 523.20615 | 218.0 |
[M]- | 523.20725 | 218.0 |